Michal Walczak

Michal Walczak

Company: Captor Therapeutics

Job title: Chief Scientific Officer & Co-founder

Seminars:

Discovery of First-In-Class Brain-Penetrant NEK7 Molecular Glue Degrader For the Treatment of Neuroinflammation 4:00 pm

NEK7 and its role in neuroinflammation NEK7 as a target for targeted protein degradation Spectacular properties of NEK7 molecular glue degradersRead more

day: Conference Day One

VENUE

Hilton Boston Back Bay

40 Dalton Street,
Boston,
MA 02115,
United States

LOCATION

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences Beacon
Searchlight Intelligence

SEARCH

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.